🇺🇸 FDA
Company

Galera

Galera Therapeutics

GRTX pharma USA

Quick answer

Galera is a pharma company (GRTX) headquartered in MALVERN, PA, USA with 17 tracked pipeline programs.

Pipeline (17)

project

GC4419 90mg

Oral Mucositis

Phase 3 · small_molecule · completed

1 trials project

Drug GC4711

SBRT

Phase 2 · small_molecule · terminated

1 trials project

Drug: GC4419

Head and Neck Cancer

Phase 2 · small_molecule · completed

1 trials project

GC4419

Pancreatic Cancer

Phase 2 · small_molecule · completed

1 trials project

GC4419

Covid19

Phase 2 · small_molecule · terminated

1 trials project

GC4419 (avasopasem manganese)

Esophagitis

Phase 2 · small_molecule · terminated

1 trials project

GC4711 +SBRT

SBRT

Phase 2 · small_molecule · terminated

1 trials project

Low Dose GC4419: 30mg/day

Radiation Induced Oral Mucositis

Phase 2 · small_molecule · completed

1 trials project

Dextromethorphan HBr

Healthy

Phase 1 · small_molecule · completed

1 trials project

GC4419

Healthy Volunteers

Phase 1 · small_molecule · completed

1 trials project

GC4419

Renal Impairment

Phase 1 · small_molecule · completed

1 trials project

GC4419

Squamous Cell Carcinoma of the Oral Cavity

Phase 1 · small_molecule · completed

1 trials project

GC4419 IV

Healthy Volunteers

Phase 1 · small_molecule · completed

1 trials project

GC4702 dry powder

Healthy Volunteer

Phase 1 · small_molecule · completed

1 trials project

GC4711 30 mg IV

Healthy Volunteers

Phase 1 · small_molecule · completed

1 trials project

GC4711 30mg

Healthy

Phase 1 · small_molecule · completed

1 trials project

GC4711 Oral Capsule G-101

Healthy Volunteers

Phase 1 · small_molecule · completed

1 trials

Patents (8)

patent

US 12220420

Combination therapy for cancer treatment

Expires Mon Feb 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12156863

Combination cancer therapy with pentaaza macrocyclic ring complex and ascorbate

Expires Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12077549

Pentaaza macrocyclic ring complexes possessing oral bioavailability

Expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11826373

Methods for treatment of diseases

Expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11612608

Methods of treating oral mucositis

Expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11246950

Combination cancer immunotherapy with pentaaza macrocyclic ring complex

Expires Mon Feb 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11219614

Combination cancer therapy with pentaaza macrocyclic ring complex and ascorbate

Expires Mon Jan 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11066433

Pentaaza macrocyclic ring complexes possessing oral bioavailability

Expires Mon Jul 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)